Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-03-14
DOI
10.3389/fnins.2018.00161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
- (2017) Diana Chang et al. NATURE GENETICS
- Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
- (2017) Danielle E Mor et al. NATURE NEUROSCIENCE
- Selective neuronal vulnerability in Parkinson disease
- (2017) D. James Surmeier et al. NATURE REVIEWS NEUROSCIENCE
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
- (2017) Lena F. Burbulla et al. SCIENCE
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons
- (2017) Chee Yeun Chung et al. Cell Systems
- Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
- (2016) Jon W. Werner-Allen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
- (2016) Tara Swart et al. CNS DRUGS
- Ca2+is a key factor in α-synuclein-induced neurotoxicity
- (2016) Plamena R. Angelova et al. JOURNAL OF CELL SCIENCE
- Converging roles of ion channels, calcium, metabolic stress, and activity pattern ofSubstantia nigradopaminergic neurons in health and Parkinson's disease
- (2016) Johanna Duda et al. JOURNAL OF NEUROCHEMISTRY
- Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
- (2016) Patrick P. Michel et al. NEURON
- α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
- (2016) Roberto Di Maio et al. Science Translational Medicine
- Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
- (2016) Qingde Zhou et al. Nature Communications
- Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
- (2016) Timothy J. Collier et al. Frontiers in Neuroscience
- Loss of hepatic chaperone-mediated autophagy accelerates proteostasis failure in aging
- (2015) Jaime L. Schneider et al. AGING CELL
- Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure
- (2015) Se Joon Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from thelocus coeruleus
- (2015) Kazumasa Wakamatsu et al. JOURNAL OF NEUROCHEMISTRY
- A concerted action of L- and T-type Ca2+ channels regulates locus coeruleus pacemaking
- (2015) Lina A. Matschke et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Mitochondrial Dysfunction andα-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
- (2015) Michela Zaltieri et al. Parkinsons Disease
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons
- (2014) Elena Dragicevic et al. BRAIN
- Deficient Chaperone-Mediated Autophagy in Liver Leads to Metabolic Dysregulation
- (2014) Jaime L. Schneider et al. Cell Metabolism
- Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice
- (2014) Meike Diepenbroek et al. HUMAN MOLECULAR GENETICS
- Differential Neuroprotective and Anti-Inflammatory Effects of L-Type Voltage Dependent Calcium Channel and Ryanodine Receptor Antagonists in the Substantia Nigra and Locus Coeruleus
- (2014) Sarah C. Hopp et al. Journal of Neuroimmune Pharmacology
- Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area
- (2014) Yudan Liu et al. JOURNAL OF NEUROPHYSIOLOGY
- -Synuclein Is Localized to Mitochondria-Associated ER Membranes
- (2014) C. Guardia-Laguarta et al. JOURNAL OF NEUROSCIENCE
- Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum
- (2014) C. Pifl et al. JOURNAL OF NEUROSCIENCE
- Mutant α-Synuclein Enhances Firing Frequencies in Dopamine Substantia Nigra Neurons by Oxidative Impairment of A-Type Potassium Channels
- (2014) Mahalakshmi Subramaniam et al. JOURNAL OF NEUROSCIENCE
- Exogenous -Synuclein Decreases Raft Partitioning of Cav2.2 Channels Inducing Dopamine Release
- (2014) G. Ronzitti et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein forms non-selective cation channels and stimulates ATP-sensitive potassium channels in hippocampal neurons
- (2014) Sergej L. Mironov JOURNAL OF PHYSIOLOGY-LONDON
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Levodopa: Effect on cell death and the natural history of Parkinson's disease
- (2014) C. Warren Olanow MOVEMENT DISORDERS
- Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase
- (2014) Javier Sanchez-Padilla et al. NATURE NEUROSCIENCE
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
- (2014) David S. Goldstein et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
- (2014) Che-Hong Chen et al. PHYSIOLOGICAL REVIEWS
- Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
- (2014) Kelly M. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Calcineurin determines toxic versus beneficial responses to -synuclein
- (2014) G. Caraveo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
- (2014) Mathieu Bourdenx et al. Frontiers in Neuroanatomy
- Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
- (2014) Marta Swirski et al. Alzheimers Research & Therapy
- The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering
- (2013) D. Ottolini et al. HUMAN MOLECULAR GENETICS
- Distribution of parvalbumin, calbindin and calretinin containing neurons and terminal networks in relation to sleep associated nuclei in the brain of the giant Zambian mole-rat (Fukomys mechowii)
- (2013) Adhil Bhagwandin et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Calcium Entry and -Synuclein Inclusions Elevate Dendritic Mitochondrial Oxidant Stress in Dopaminergic Neurons
- (2013) D. I. Dryanovski et al. JOURNAL OF NEUROSCIENCE
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- Neuromelanin of the Human Substantia Nigra: An Update
- (2013) Fabio A. Zucca et al. NEUROTOXICITY RESEARCH
- Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons
- (2013) Jonathan A. Doorn et al. PARKINSONISM & RELATED DISORDERS
- Large -synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking
- (2013) B.-K. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- Functional Neuroimaging in Parkinson's Disease
- (2013) M. Niethammer et al. Cold Spring Harbor Perspectives in Medicine
- Use of Calcium Channel Blockers and Parkinson’s Disease
- (2012) Björn Pasternak et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- α-Synuclein oligomers and clinical implications for Parkinson disease
- (2012) Lorraine V. Kalia et al. ANNALS OF NEUROLOGY
- Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
- (2012) Nicole Exner et al. EMBO JOURNAL
- α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions
- (2012) Tito Calì et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
- (2012) D. James Surmeier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
- (2012) Joshua A Goldberg et al. NATURE NEUROSCIENCE
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Potassium Depolarization and Raised Calcium Induces α-Synuclein Aggregates
- (2012) Jordan Follett et al. NEUROTOXICITY RESEARCH
- Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
- (2012) Margaret Chia-Ying Wey et al. PLoS One
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
- (2011) Celine Perier et al. ANTIOXIDANTS & REDOX SIGNALING
- Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
- (2011) G. J. Masilamoni et al. BRAIN
- The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis
- (2011) Karin D. van Dijk et al. BRAIN PATHOLOGY
- A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse
- (2011) YuHong Fu et al. Brain Structure & Function
- Distinct Roles In Vivo for the Ubiquitin-Proteasome System and the Autophagy-Lysosomal Pathway in the Degradation of -Synuclein
- (2011) D. Ebrahimi-Fakhari et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Voltage-gated calcium channels and Parkinson's disease
- (2011) Michael J. Hurley et al. PHARMACOLOGY & THERAPEUTICS
- Tyrosine hydroxylase and regulation of dopamine synthesis
- (2010) S. Colette Daubner et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2Ain Vitroandin Vivo
- (2010) Haiyan Lou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Raised calcium promotes α-synuclein aggregate formation
- (2010) S. Nath et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Protein degradation, aggregation, and misfolding
- (2010) Ana Maria Cuervo et al. MOVEMENT DISORDERS
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
- (2010) Venu M. Nemani et al. NEURON
- -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
- (2010) J. Burre et al. SCIENCE
- Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum
- (2009) W. Matsuda et al. JOURNAL OF NEUROSCIENCE
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
- (2009) Eugene V. Mosharov et al. NEURON
- Dopamine-Induced Conformational Changes in Alpha-Synuclein
- (2009) Tiago F. Outeiro et al. PLoS One
- Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: Implications for Parkinson’s disease and protection by polyphenols
- (2008) David Vauzour et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Enhancing Aromatic L-amino Acid Decarboxylase Activity: Implications for L-DOPA Treatment in Parkinson's Disease
- (2008) Maria Hadjiconstantinou et al. CNS Neuroscience & Therapeutics
- Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
- (2008) Marta Martinez-Vicente et al. JOURNAL OF CLINICAL INVESTIGATION
- Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice
- (2008) L. Chen et al. JOURNAL OF NEUROSCIENCE
- Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
- (2008) Fernando E. Herrera et al. PLoS One
- Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
- (2007) Daniel Alvarez-Fischer et al. EXPERIMENTAL NEUROLOGY
- Calcium(II) selectively induces α-synuclein annular oligomers via interaction with the C-terminal domain
- (2004) Rachel Lowe et al. PROTEIN SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started